Sollmann T (1917)

The crucial test of therapeutic evidence. JAMA 69:198-199.
In 1917 Thorkild Sollmann, in an editorial published in JAMA, drew attention to the poor quality of reports of clinical studies, and too close a relationship between researchers and those manufacturing and selling drugs.

Key passage(s)

Sollmann-1917-kp1 Sollmann-1917-kp2

Whole article

Download the full article as a PDF 

Sollmann T (1917). The crucial test of therapeutic evidence. JAMA 69:198-199.

Portrait(s)

Torald Herman Sollmann 1874-1965

Acknowledgements

The editors are grateful to:

JAMA for allowing the James Lind Library to link to this and other articles of historical relevance (email to Iain Chalmers from Annette Flanagin, 29 August 2014).

RELEVANT TOPICS

Key articles

  • Altman DG, Simera I (2015).
    A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network.
  • Jefferson T (2019).
    Sponsorship bias in clinical trials – growing menace or dawning realisation?
  • Podolsky SH (2022).
    The (Harry) Gold Standard: angina, suggestion, and the path to the “double-blind” test and Clinical Pharmacology.

Other articles

All topics

BROWSE

Topics
Essays
Records
Articles

ABOUT

What is a fair test?
About the Library
Building the Library
Using the Library

COPYRIGHT

Where not otherwise indicated, material in the James Lind Library is licensed under a Creative Commons Attribution 4.0 International License.

FEEDBACK

Contact us

We welcome your suggestions for the design or content of the Library

Website by Minervation Ltd, supported by the James Lind Initiative and the Presidential Fund of the Swiss National Science Foundation.